Using the PSM program, we matched two groups by adjusting for age, tumor location, tumor grade, T stage, N stage, ER status, HER2/neu status, and type of therapy (surgery, radiation, and chemotherapy)(Supplemental file‐PS matching). This evidence concerns the gene ESR1 and neoplasm.